These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20490465)

  • 1. Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.
    Cooper ZD; Haney M
    Psychopharmacology (Berl); 2010 Aug; 211(2):141-8. PubMed ID: 20490465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between naltrexone and oral THC in heavy marijuana smokers.
    Haney M; Bisaga A; Foltin RW
    Psychopharmacology (Berl); 2003 Feb; 166(1):77-85. PubMed ID: 12491025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers.
    Haney M
    Neuropsychopharmacology; 2007 Jun; 32(6):1391-403. PubMed ID: 17091128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marijuana's dose-dependent effects in daily marijuana smokers.
    Ramesh D; Haney M; Cooper ZD
    Exp Clin Psychopharmacol; 2013 Aug; 21(4):287-93. PubMed ID: 23937597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans.
    Wachtel SR; de Wit H
    Drug Alcohol Depend; 2000 Jun; 59(3):251-60. PubMed ID: 10812285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of sex-dependent effects of cannabis in daily cannabis smokers.
    Cooper ZD; Haney M
    Drug Alcohol Depend; 2014 Mar; 136():85-91. PubMed ID: 24440051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.
    Bedi G; Cooper ZD; Haney M
    Addict Biol; 2013 Sep; 18(5):872-81. PubMed ID: 22260337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive, subjective and behavioral effects of smoked marijuana in humans.
    Greenwald MK; Stitzer ML
    Drug Alcohol Depend; 2000 Jun; 59(3):261-75. PubMed ID: 10812286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers.
    Cooper ZD; Comer SD; Haney M
    Neuropsychopharmacology; 2013 Sep; 38(10):1984-92. PubMed ID: 23609132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans.
    Ranganathan M; Carbuto M; Braley G; Elander J; Perry E; Pittman B; Radhakrishnan R; Sewell RA; D'Souza DC
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1251-64. PubMed ID: 22243563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers.
    Haney M; Ramesh D; Glass A; Pavlicova M; Bedi G; Cooper ZD
    Neuropsychopharmacology; 2015 Oct; 40(11):2489-98. PubMed ID: 25881117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marijuana's acute effects on cognitive bias for affective and marijuana cues.
    Metrik J; Aston ER; Kahler CW; Rohsenow DJ; McGeary JE; Knopik VS
    Exp Clin Psychopharmacol; 2015 Oct; 23(5):339-50. PubMed ID: 26167716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood.
    Haney M; Rabkin J; Gunderson E; Foltin RW
    Psychopharmacology (Berl); 2005 Aug; 181(1):170-8. PubMed ID: 15778874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of pharmacodynamic effects following oral administration of crushed morphine sulfate and naltrexone hydrochloride extended-release capsules compared with crushed morphine sulfate controlled-release tablets and placebo in nondependent recreational opioid users.
    Setnik B; Sommerville K; Goli V; Han L; Webster L
    Pain Med; 2013 Aug; 14(8):1173-86. PubMed ID: 23745947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys.
    Justinova Z; Tanda G; Munzar P; Goldberg SR
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):186-94. PubMed ID: 14668977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers.
    Babalonis S; Haney M; Malcolm RJ; Lofwall MR; Votaw VR; Sparenborg S; Walsh SL
    Drug Alcohol Depend; 2017 Mar; 172():9-13. PubMed ID: 28088032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.
    Haney M; Cooper ZD; Bedi G; Vosburg SK; Comer SD; Foltin RW
    Neuropsychopharmacology; 2013 Jul; 38(8):1557-65. PubMed ID: 23443718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects.
    McCaul ME; Wand GS; Eissenberg T; Rohde CA; Cheskin LJ
    Neuropsychopharmacology; 2000 May; 22(5):480-92. PubMed ID: 10731623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone.
    Bisaga A; Sullivan MA; Glass A; Mishlen K; Pavlicova M; Haney M; Raby WN; Levin FR; Carpenter KM; Mariani JJ; Nunes EV
    Drug Alcohol Depend; 2015 Sep; 154():38-45. PubMed ID: 26187456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.
    Comer SD; Mogali S; Saccone PA; Askalsky P; Martinez D; Walker EA; Jones JD; Vosburg SK; Cooper ZD; Roux P; Sullivan MA; Manubay JM; Rubin E; Pines A; Berkower EL; Haney M; Foltin RW
    Neuropsychopharmacology; 2013 Nov; 38(12):2427-38. PubMed ID: 23736314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.